Dec 03, 2019
Imaging Reveals Pathways Behind Depression
Nov 18, 2019
Pharmactive Affron® Saffron Helps Beat the Blues
Nov 13, 2019
Preventing Depression in Pregnant Mothers May Have Lasting Impact for Generations
Nov 12, 2019
Dr. Gregory Jantz Explains Signs and Symptoms of Depression and Anxiety for the Holidays
Oct 22, 2019
Actify Launches New 360-Degree Treatment Model for People Living with Depression and Anxiety Disorders
Oct 21, 2019
Neuronetics CEO Chris Thatcher to Ring Nasdaq Closing Bell on October 22 in Honor of National Depression Awareness Month
Oct 20, 2019
Juvenile Bipolar Research Foundation Hires Executive Director
Oct 15, 2019
Relmada Therapeutics Announces Top-Line Results from REL-1017 Phase 2 Study in Individuals with Treatment Resistant Depression
Oct 10, 2019
PhRMA Report Shows Nearly 140 Medicines in Development to Treat Mental Illness
Oct 08, 2019
CT Psychiatrist Shows Titrated IV Ketamine Can STOP Suicidality
Oct 08, 2019
Healthcare Real Estate Development Company, Simone Health, Explains How Bright Lighting Levels Affect Hospital Patients
Oct 03, 2019
Neuronetics® Unveils Promising New Depression Research Data at Psych Congress
Sep 30, 2019
Postpartum Depression Market Global Insights, Drugs, 7MM Coverage, Epidemiology and Forecasts to 2028
Sep 09, 2019
NeuroRX to Present at the H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019
Sep 04, 2019
Neuronetics® Announces Greenbrook® TMS Installation Milestone for NeuroStar® Advanced Therapy System
Sep 03, 2019
US Bipolar Disorder Market and Competitive Landscape 2019-2024: Treatments, Pipeline, Epidemiology, Marketed Drugs, Size, Sales, Competitive Landscape
Aug 29, 2019
Depression Drugs Market to Generate US$ 5000 Million Revenue by 2026, Online Pharmacies to Gain Market Share - TMR
Aug 28, 2019
Discovery Mood and Anxiety Program Opens Treatment Program For Youth In Orlando
Aug 19, 2019
Researchers at USU Unveil Neuronetics®-supported Clinical Research for PTSD and Traumatic Brain Injury at the Military Health System Research Symposium
Aug 01, 2019
Neuronetics® Announces First TMS Patient Treated Under New Japan Reimbursement Policy